{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:10:38Z","timestamp":1792757438516,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1001\/jamapsychiatry.2019.1189","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:02:35Z","timestamp":1559732555000},"page":"893","source":"Crossref","is-referenced-by-count":610,"title":["Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression"],"prefix":"10.1001","volume":"76","author":[{"given":"Ella J.","family":"Daly","sequence":"first","affiliation":[{"name":"Department of  Neuroscience, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Janik","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Janssen Research and Development LLC, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of  Neuroscience, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Janssen Research and Development LLC, Fremont, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Janssen Research and Development LLC, Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Duca","sequence":"additional","affiliation":[{"name":"Department of  Neuroscience, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hough","sequence":"additional","affiliation":[{"name":"Department of  Neuroscience, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zajecka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Winokur","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Connecticut Health, Farmington"},{"name":"Institute of Living, Hartford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Divacka","sequence":"additional","affiliation":[{"name":"Private practice, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fagiolini","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Division of Psychiatry, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieslaw J.","family":"Cubala","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Bitter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry and Cellular\/Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Shelton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Alabama School of Medicine, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Molero","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Clinica Universidad de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husseini","family":"Manji","sequence":"additional","affiliation":[{"name":"Department of  Neuroscience, Janssen Research and Development LLC, Titusville, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne C.","family":"Drevets","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Janssen Research and Development LLC, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskaran B.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Janssen Research and Development LLC, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"yoi190033r2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"yoi190033r3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"10","key":"yoi190033r5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.","volume":"172","author":"Newport","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"8","key":"yoi190033r6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"yoi190033r7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"6","key":"yoi190033r8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study.","volume":"80","author":"Singh","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"8","key":"yoi190033r9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression.","volume":"173","author":"Singh","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi190033r10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: results of a double-blind, doubly-randomized, placebo-controlled study.","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi190033r11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/bjp.bp.106.032532","article-title":"Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).","volume":"192","author":"Williams","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"4","key":"yoi190033r13","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.biopsych.2012.02.039","article-title":"On the safety and benefits of repeated intravenous injections of ketamine for depression.","volume":"72","author":"Blier","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yoi190033r14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1590\/1516-4446-2017-2380","article-title":"Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study.","volume":"40","author":"Barenboim","year":"2018","journal-title":"Braz J Psychiatry"},{"issue":"20","key":"yoi190033r16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"yoi190033r18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0033291703001107","article-title":"The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychol Med"},{"issue":"7","key":"yoi190033r20","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","article-title":"Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA\u2019s pediatric suicidal risk analysis of antidepressants.","volume":"164","author":"Posner","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi190033r21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS).","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"yoi190033r22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"issue":"4","key":"yoi190033r23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/JCP.0b013e31817efbac","article-title":"Physician Withdrawal Checklist (PWC-20).","volume":"28","author":"Rickels","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"yoi190033r24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2307\/2531959","article-title":"Approximately optimal one-parameter boundaries for group sequential trials.","volume":"43","author":"Wang","year":"1987","journal-title":"Biometrics"},{"issue":"4","key":"yoi190033r25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/(ISSN)1521-4036","article-title":"Planning and analyzing adaptive group sequential survival trials.","volume":"48","author":"Wassmer","year":"2006","journal-title":"Biom J"},{"issue":"3","key":"yoi190033r26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4088\/JCP.13r08722","article-title":"Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration.","volume":"75","author":"Borges","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"yoi190033r27","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jama.285.10.1299","article-title":"Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.","volume":"285","author":"Sackeim","year":"2001","journal-title":"JAMA"},{"key":"yoi190033r15","author":"Fedgchin","year":"2018"},{"key":"yoi190033r17","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"yoi190033r1","unstructured":"World Health Organization, Media Centre, Depression Fact Sheet, Updated 22 March. 2018. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/depression. Accessed December 26, 2018."},{"key":"yoi190033r4","unstructured":"Agency for Healthcare Research and Quality. Definition of treatment-resistant depression in the Medicare population. https:\/\/www.ahrq.gov\/sites\/default\/files\/wysiwyg\/research\/findings\/ta\/drafts-for-review\/trd-draft.pdf. Accessed October 23, 2018."},{"key":"yoi190033r12","unstructured":"PopovaV, DalyE, TrivediM, . Randomized, double-blind study of flexibly-dosed intranasal esketamine plus oral antidepressant vs active control in treatment-resistant depression. Paper presented at: 2018 American Society for Clinical Pathology Annual Meeting; May 30, 2018; Miami, FL. https:\/\/pmg.joynadmin.org\/documents\/1005\/5afde1ec68ed3f2e245822b9.pdf. Accessed May 7, 2019."},{"key":"yoi190033r19","unstructured":"ClinicalTrials.gov. A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-3). NCT02782104. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02782104. Accessed April 2, 2019."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/article-pdf\/76\/9\/893\/17851981\/jamapsychiatry_daly_2019_oi_190033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T12:17:02Z","timestamp":1567599422000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2735111"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1189","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}